SENSIENT TECHNOLOGIES CORP (SXT)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SXT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SXT | Director | 71 | ["Interim President, University of Florida (2025-present)","Member of the faculty of Columbia University (1985-2025) (on extended leave)","Professor of Medicine at Columbia University’s College of Physicians and Surgeons (2004-2025)","Founding Director, Center for Human Longevity at Columbia University (2023-2025)","Chair of the Department of Medicine at Columbia University and Physician-in-Chief at NewYork-Presbyterian/Columbia University Medical Center (2008-2023)","Director of the Division of Experimental Therapeutics at Columbia Medical Center (1998-2021)","Founding director of Tonix Pharmaceuticals, Inc. (2007-2011)","Co-founder of Vela Pharmaceuticals, a private company that developed drugs for central nervous system disorders","Co-founder of Tegrigen Therapeutics, LLC","Member of the President’s Council on Bioethics during the George W. Bush administration","Awarded the Presidential Citizens Medal (2008)","Elected to the National Academy of Inventors (2016)","Expert in the medical and pharmaceutical fields"] | ["Compensation and Development Committee","Nominating and Corporate Governance Committee","Scientific Advisory Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age 71 Director Since 2015 Compensation and Development Committee Nominating and Corporate Governance Committee (Chairman) Scientific Advisory Committee Professional Experience: Interim President, University of Florida (2025-present) Member of the faculty of Columbia University (1985-2025) (on extended leave) Professor of Medicine at Columbia University s College of Physicians and Surgeons (2004-2025) Founding Director, Center for Human Longevity at Columbia University (2023-2025) Chair of the Department of Medicine at Columbia University and Physician-in-Chief at NewYork-Presbyterian/Columbia University Medical Center (2008-2023) Director of the Division of Experimental Therapeutics at Columbia Medical Center (1998-2021) Founding director of Tonix Pharmaceuticals, Inc., a wholly-owned subsidiary of Tonix Pharmaceuticals Holding Corp. (2007-2011) Co-founder of Vela Pharmaceuticals, a private company that developed drugs for central nervous system disorders Co-founder of Tegrigen Therapeutics, LLC, a private company that developed novel therapeutics for inflammation, fibrosis, thrombosis, autoimmunity, and cancer based on pure orthosteric antagonists to specific integrins. Other Recent Public Company Directorships: Tonix Pharmaceuticals Holding Corp. (2011-2019), a pharmaceutical company that develops next-generation medicines for common disorders of the central nervous system, including fibromyalgia, post-traumatic stress disorder, and episodic tension-type headache Other Experience: Lafayette College, B.S. in chemistry (1975) Harvard University, Ph.D. in organic chemistry (1979) Columbia University s College of Physicians and Surgeons, M.D. (1983) Developed the first artificial enzyme to degrade cocaine and his report in Science was voted one of top 25 papers in the world for 1993 by the American Chemical Society Discovered that vasopressin can be used to treat vasodilatory shock, which fundamentally changed intensive care practice for this condition Pioneered an embryo-sparing approach to the generation of human embryonic stem cells Served as a member of the President s Council on Bioethics during the George W. Bush administration Awarded the Presidential Citizens Medal, the nation s second-highest civilian award (2008) Elected to the National Academy of Inventors (2016) National Institutes of Health (NIH) Physician-Scientist, Columbia University (1985-1990) Published 125 peer-reviewed articles, authored 37 review articles or book chapters, and awarded 51 patents as inventor or co-inventor Qualifications: Expert in the medical and pharmaceutical fields and has unique experiences in the formation, operation, and public registration of a start-up pharmaceutical company; and Experience as director of a public corporation; experience in commercialization of new products and in research and development; strong technical acumen in chemistry, medicine, and the pharmaceutical industry and other fields related to our business; and academic background.